Compare PNTG & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PNTG | PSNL |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2019 | 2019 |
| Metric | PNTG | PSNL |
|---|---|---|
| Price | $38.28 | $17.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $37.00 | $12.20 |
| AVG Volume (30 Days) | 250.3K | ★ 3.4M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.00 | ★ 33.58 |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $947,705,000.00 | $69,648,000.00 |
| Revenue This Year | $24.72 | $15.34 |
| Revenue Next Year | $7.61 | $41.46 |
| P/E Ratio | $78.06 | ★ N/A |
| Revenue Growth | ★ 36.31 | N/A |
| 52 Week Low | $22.26 | $4.65 |
| 52 Week High | $42.69 | $18.89 |
| Indicator | PNTG | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 67.04 |
| Support Level | $37.95 | $7.36 |
| Resistance Level | $42.62 | N/A |
| Average True Range (ATR) | 1.12 | 0.78 |
| MACD | -0.16 | 0.33 |
| Stochastic Oscillator | 19.89 | 72.57 |
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.